Sunshine Biopharma (SBFM) EBT (2016 - 2025)
Historic EBT for Sunshine Biopharma (SBFM) over the last 13 years, with Q3 2025 value amounting to -$1.0 million.
- Sunshine Biopharma's EBT fell 393.57% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.5 million, marking a year-over-year decrease of 5828.03%. This contributed to the annual value of -$5.4 million for FY2024, which is 3060.41% down from last year.
- Per Sunshine Biopharma's latest filing, its EBT stood at -$1.0 million for Q3 2025, which was down 393.57% from -$2.0 million recorded in Q2 2025.
- In the past 5 years, Sunshine Biopharma's EBT ranged from a high of $667116.0 in Q4 2021 and a low of -$23.3 million during Q4 2022
- Over the past 5 years, Sunshine Biopharma's median EBT value was -$1.2 million (recorded in 2022), while the average stood at -$2.8 million.
- The largest annual percentage gain for Sunshine Biopharma's EBT in the last 5 years was 16155.38% (2021), contrasted with its biggest fall of 646184.13% (2021).
- Quarter analysis of 5 years shows Sunshine Biopharma's EBT stood at $667116.0 in 2021, then crashed by 3589.5% to -$23.3 million in 2022, then soared by 95.58% to -$1.0 million in 2023, then plummeted by 122.09% to -$2.3 million in 2024, then soared by 55.34% to -$1.0 million in 2025.
- Its EBT stands at -$1.0 million for Q3 2025, versus -$2.0 million for Q2 2025 and -$1.2 million for Q1 2025.